Study: Polypill linked to lower risk of heart disease

01/18/2013 | Capital Times (Madison, Wis.), The

A polypill that includes aspirin, a statin and three blood pressure lowering drugs could lower the lifetime risk of heart disease by 21% in men and 15% in women, a study in Latin America found. The polypill "would be cost-effective and could also be cost-saving," study leader Leonelo Bautista said. The study was published in the journal Health Affairs.

View Full Article in:

Capital Times (Madison, Wis.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY